Short answer
3D SYSTEMS CORP (DDD) filed its fiscal 2025 10-K annual report with the SEC on Mar 9, 2026. It reported revenue of $387M (−12.1% year over year) and net income of $30M.
- Top risk flagged: Regulatory risk: Non-compliance with US Toxic Substances Control Act (TSCA) and EU REACH may incur fines, reformulation costs, and civil/criminal penalties
FY2025 key financial metrics · XBRL
- Revenue
- $387M
- −12.1% YoY
- Net income
- $30M
- +111.7% YoY
- Operating margin
- -24.8%
- +38.2 pp YoY
- Gross margin
- 33.9%
- −3.4 pp YoY
- EPS (diluted)
- $0.19
- +109.8% YoY
- ROE
- 12.4%
- +157.5 pp YoY
- Operating cash flow
- −$88M
- −95.7% YoY
Source: XBRL data from the 3D SYSTEMS CORP (DDD) FY2025 10-K on SEC EDGAR. USD.
3D SYSTEMS CORP FY2025 10-K analysis
AI summary of each section, grounded in the filing text
Business Overview
- Core business: End-to-end 3D printing and digital manufacturing solutions for Healthcare and Industrial verticals
- New emphasis on Regenerative Medicine R&D targeting scalable 3D printed human lungs for transplantation
- Strategic focus on enabling additive manufacturing adoption and scaling through integrated hardware, software, materials, and services
- Employee count declined 23% to 1,418 in 2025 from 1,833 in 2024, reflecting restructuring efforts
- Divestiture of 3DXpert business in 2025 with continued support via Hubb Ventures partnership
Management Discussion & Analysis
- Revenue $386.9M, down 12.1% YoY from $440.1M due to $55.8M product revenue decline; services revenue up $2.6M
- Gross profit $131.0M, down 20.2%; gross margin 33.9% vs 37.3% YoY, due to divestitures and lower sales volumes
- Best segment Healthcare Solutions: revenue $179.6M (-5.3%), gross profit $71.8M (-2.3%); worst Industrial Solutions: revenue $207.3M (-17.2%), gross profit $59.2M (-34.7%)
- Cash $95.6M down $75.7M; operating cash used $87.8M; net repayments of debt $170M; share repurchases $15M; capex $9.9M; investing inflows $122.7M from asset sales
- Management expects cash flow, cash and financing sources sufficient for 12-month liquidity; risks include macroeconomic uncertainty and debt covenant compliance
Risk Factors
- Regulatory risk: Non-compliance with US Toxic Substances Control Act (TSCA) and EU REACH may incur fines, reformulation costs, and civil/criminal penalties
- Geopolitical risk: Trade policy changes could disrupt supply chain and increase costs, affecting sourcing, manufacturing, and distribution operations
- Supply chain risk: Dependence on single or limited suppliers for lasers, materials, and jetting components risks shortages and delivery delays impacting production
- Competitive risk: Quality problems in complex hardware/software products risk lost sales, warranty claims, and reputation damage in aerospace, medical, and semiconductor markets
- Financial risk: $92.0M principal outstanding on 5.875% convertible senior secured notes due 2030 requires cash flow compliance to avoid event of default and immediate repayment
Generated from the filing text; verify against the original. How to read a 10-K
Ask about this 10-K
Compare years, dig into a risk factor or check the numbers against insider trades and fund holders.